Latest News
Biogen and Sage ink $1.5bn deal to develop anti-depression treatments
Biogen has inked a deal with Sage Therapeutics to jointly develop and sell potentially "breakthrough" treatments for major depressive and movement disorders in the US.
Liberum upgrades Mind Gym to 'buy'
Analysts at Liberum upgraded behavioural sciences group Mind Gym to 'buy' on Friday, stating the company's interim results were a "turning point".
Indivior tumbles as Reckitt Benckiser makes £1bn claim
Indivior shares tumbled on Friday after the opioid addiction treatment maker said it had been made aware of a £1. 07bn claim against it by consumer goods company Reckitt Benckiser.
UK Black Friday online sales expected to beat record
Internet industry body IMRG said that the online sales for this year’s Black Friday are expected to reach an all-time high.
US pre-open: Futures point to small gains for holiday-shortened session
Wall Street futures had stocks opening slightly higher ahead of the bell on Friday's shortened session after traders took a day off to celebrate Thanksgiving.
CMA to announce plans to limit power of tech giants in UK
The Competition and Markets Authority is set to announce plans to limit the power of Google, Facebook and other tech giants to allow space for competition for smaller businesses.
Edenville flags delay to Rukwa handover as it faces cash crisis
Edenville Energy, which operates the Rukwa Coal Project in southwest Tanzania, updated the market on its operations on Friday, reporting that the mine was continuing to fulfil its pre-purchase orders.
Ixico executes contract for Huntington's disease clinical trial
Neuroscience data analytics company Ixico has executed a contract to provide neuroimaging services that would support a phase 1b and 2 clinical trial for Huntington's disease, it announced on Friday.
DeepVerge posts positive results of Covid-19 tests on lab-grown skin
DeepVerge announced interim results from its Labskin partnership with the University of Aberdeen on Friday, following analysis of a study to investigate the behaviour of the SARS-CoV-2 virus on Labskin's cloned human skin microbiome, to enable testing of Covid-19 anti-viral and dental products.
London midday: Stocks drift lower as investors digest Covid tiers
London stocks were off earlier lows but still a little weaker by midday on Friday as investors mulled the economic impact of coronavirus restrictions following news on England’s post-lockdown tiers.
Immunodiagnostic Systems launces two rapid Covid-19 tests
Clinical laboratory diagnostics company Immunodiagnostic Systems announced on Friday that two SARS-CoV-2 antigen rapid test kits for Covid-19 were now available for sale in the UK, the European Union, and other countries which accept the CE-mark as the basis of regulatory approval.
Arcadia confirms looking at 'contingency options' as Covid hammers sales
Top Shop owner Arcadia said it was looking at a number of options to save the future of its brands after reports on Friday suggested the retail group could was teetering on the edge of administration.
Providence offers vague response to Barryroe farm-out reports
Ireland-based development company Providence Resources responded to recent media speculation over the status of farm-out discussions with SpotOn Energy on Friday.
Europe midday: Shares still seek direction in listless trade
European shares meandered to lunch on Friday, with a weaker London market dragging on sentiment as the UK government unveiled tough new post-lockdown measures.
RBC Capital raises target price on John Wood
Analysts at RBC Capital Markets raised their target price on multinational energy services company John Wood Group from 300. 0p to 360. 0p on Friday following a guidance update from the firm's board.
Europe open: UK proves a drag for shares in subdued market
European shares started the final session of the week slightly lower, with a weaker London market dragging on sentiment as the UK government unveiled new post-lockdown measures.
Michelmersh capacity back in line with pre-Covid levels
Brick manufacturer Michelmersh said on Friday that its trading performance since June had been "resilient", with current capacity back in line with pre-Covid levels and turnover ahead 7% year-on-year.
Asia report: Most markets higher as China industrial profits surge
Most markets in Asia finished higher on Friday, as investors digested the latest manufacturing data from China, and watched for the latest developments in the ongoing Covid-19 pandemic.
Goldman downgrades Marks & Spencer to 'neutral'
Marks & Spencer was under pressure on Friday after Goldman Sachs downgraded its rating on the retailer to ‘neutral’ from ‘buy’, citing limited upside.
Sabadell shares slide as merger talks with BBVA end
Shares of Banco de Sabadell tumbled on Friday after it said merger talks with Banco Bilbao Vizcaya Argentaria (BBVA) have ended due to a disagreement over price.